Skip to main content

We have updated our Privacy Notice to improve clarity, but our data practices remain the same.

  • MND Connect Helpline: 0808 802 6262
  • Fundraising enquiries: 01604 611860
  • News
  • About us
  • Shop
Donate
  • Understanding MND
    • MND explained
      • MND explained
      • What is MND?
      • What is Kennedy's Disease?
      • Early signs of MND
      • Newly diagnosed?
      • What causes MND?
      • Information resources
      • Information in other languages and formats
    • Living with MND
      • Living with MND
      • Mobility and movement
      • Personal care
      • Speech and communication
      • Swallowing, eating and drinking
      • Emotions, thinking and behaviour
      • Breathing and ventilation
      • Relationships
      • Safety at home
    • Getting health and social care
      • Getting health and social care
      • MND checklist
      • MND Views
      • Types of care and who provides them
      • Needs assessment, home care and home adaptations
      • Benefits, financial support and cost of living
      • Treatments and medication
      • Getting the right treatment or care with MND
      • Planning future care
    • By relationship
      • By relationship
      • Information for carers
      • Information for family members and partners
      • Information for children, young people, parents and guardians

    Search for information resources by need

    Search now
  • Support we offer
    • Practical and financial support
      • Practical and financial support
      • Benefits advice service
      • Voice banking and communication aids
      • Financial support funds
      • Wheelchair support
      • Will writing
    • Care and personal support
      • Care and personal support
      • Health and social care services
      • Local support
      • Home visits
      • Care centres and networks
    • Helpline (MND Connect)
    • Online forum
    • Bereavement support
  • Professionals
    • Management of MND
      • Management of MND
      • Cognitive change, dementia and psychological support
      • Diagnosis
      • Dysarthria (speech difficulties)
      • Dysphagia (swallowing difficulties), nutrition and saliva
      • Genetics
      • Kennedy's disease
      • NHS Continuing Healthcare (CHC)
    • Education and development
      • Education and development
      • Community of practice
      • Upcoming events
      • Webinar recordings
      • Online courses
      • Latest news
    • Refer someone to us
      Make a referral

    Search for information resources by topic or profession

    Search now
  • Research
    • Research
      • Research
      • Our research
      • Take part in a clinical trial
      • For researchers
      • Apply for research funding
      • Longitude Prize on ALS
    • Studies we fund
      • Studies we fund
      • Understand: Revealing causes and targets
      • Discover: New treatments for everyone
      • Detect: Better and earlier diagnosis
      • Innovate: Innovations in healthcare
    • Join the MND Register
    • Using animals and stem cells in our research
    • Unproven treatments
    • How drugs are developed in the UK
    • International Symposium
    • Join TiM-R
    • Latest research news
      Explore MND research
  • Get involved
    • Fundraising
      • Fundraising
      • Fundraising events
      • Fundraise your way
      • Leave a gift in your will
      • Corporate fundraising
      • Philanthropy
    • Campaigning
      • Campaigning
      • Campaigning
      • Support our campaigns
      • Our policy positions
    • Other ways to support
      • Other ways to support
      • Make a donation
      • Give a regular donation
      • Become a member
      • Volunteer with us
    • Spring appeal
      Donate now
  • MND Connect Helpline: 0808 802 6262
  • Fundraising enquiries: 01604 611860
  • News
  • About us
  • Shop

Search results

Advanced Filters
Showing 10 of 3399 results
  • PDF
Final MIROCALS press release 08122022 0
View more
  • PDF
Amylyx Pharmaceuticals Announces FDA Approval of RELYVRIO™ for the Treatment of ALS
View more
  • PDF
US approved AMX0035 FAQ October 2022 VP
View more
  • PDF
AANEM.Rescue.Survival Final 20220922
View more
  • PDF
Amylyx Pharmaceuticals Announces FDA Advisory Committee Supports Approval of AMX0035 for the Treatment of ALS
View more
  • PDF
rare diseases orphan medicines getting facts straight en
View more
  • PDF
TOF Miller Phase3VALOR OLEreadout
View more
  • PDF
Published papers 16 05 2022
View more
  • PDF
Published papers 09 05 2022
View more
  • PDF
Published papers 02 05 2022
View more

Pagination

  • First page « First
  • Previous page Previous
  • …
  • Page 279
  • Page 280
  • Page 281
  • Page 282
  • Current page 283
  • Page 284
  • Page 285
  • Page 286
  • Page 287
  • …
  • Next page Next
  • Last page Last »

Who would you like to share this with?

We will share resources to the email address you provide. The email will include your name in the subject line and the following message: 'I have found these information resources that you may find helpful too.'

Email sent successfully

We have shared these resources with the email address you entered.

MND Connect Helpline

  • 0808 802 6262
  • Email us
  • Visit the forum

Fundraising enquiries

  • 01604 611860
  • Email us
Fundraising Regulator badge with validation link
International Alliance of ALS/MND Associations logo

Social media

  • Instagram
  • Facebook
  • Twitter
  • YouTube

Footer links

  • About us
  • Contact us
  • Work for us
  • Media
  • Privacy notice
  • Cookies policy
  • Terms and conditions
  • Purchasing terms
  • Accessibility

 © 2026 MND Association: Registered in England at Francis Crick House, 6 Summerhouse Road, Moulton Park, Northampton, NN3 6BJ. Registered Charity no. 294354. VAT Registration no. 316 4340 28.